Repression of integrin-linked kinase by antidiabetes drugs through cross-talk of PPARγ- and AMPKα-dependent signaling: Role of AP-2α and sp1

Cellular Signalling

Volumn 26, Issue 3, 2014, Pages 639-647

  Hahn, SWei Sunny ^a   Tang, Qing ^a   Zheng, Fang ^a   Zhao, Shunyu ^a   Wu, Jingjing ^a   Chen, Jianping ^b  

^a GUANGZHOU UNIVERSITY OF CHINESE MEDICINE   (China)

^b THE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

AMPK ; AP 2 ; ILK; Nasopharyngeal carcinoma cells; PPAR ; Sp1

Indexed keywords

AMP DEPENDENT KINASE ALPHA; AP 2ALPHA PROTEIN; INTEGRIN LINKED KINASE; METFORMIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PHOSPHOTRANSFERASE; ROSIGLITAZONE; TRANSCRIPTION FACTOR AP 2; TRANSCRIPTION FACTOR SP1; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; AP 2ALPHA GENE; ARTICLE; CANCER CELL; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DRUG MECHANISM; DRUG POTENTIATION; ENZYME ACTIVITY; ENZYME INHIBITION; GENE; GENE EXPRESSION; ILK GENE; MITOSIS INHIBITION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; SP1 GENE;

AMPKΑ; AP-2Α; ILK; NASOPHARYNGEAL CARCINOMA CELLS; PPARΓ; SP1;

AMP-ACTIVATED PROTEIN KINASES; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; HYPOGLYCEMIC AGENTS; METFORMIN; MUTATION; NASOPHARYNGEAL NEOPLASMS; PPAR GAMMA; PROMOTER REGIONS, GENETIC; PROTEIN-SERINE-THREONINE KINASES; RNA INTERFERENCE; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; SP1 TRANSCRIPTION FACTOR; THIAZOLIDINEDIONES; TRANSCRIPTION FACTOR AP-2;

EID: 84891808975     PISSN: 08986568     EISSN: 18733913     Source Type: Journal    
DOI: 10.1016/j.cellsig.2013.12.004     Document Type: Article

References (39)

1. Xu Y., Zhang J., Shi W., Liu Y. Oncol. Lett. 2013, 5:655-662.
2. Pan Y., Zhou F., Zhang R., Claret F.X. PLoS One 2013, 8:e54565.
3. Lo A.K., Lo K.W., Ko C.W., Young L.S., Dawson C.W. J. Pathol. 2013, 230:336-346.
4. Klubo-Gwiezdzinska J., Costello J., Patel A., Bauer A., Jensen K., Mete M., Burman K.D., Wartofsky L., Vasko V. J Clin Endocrinol Metab. 2013, 98:3269-3279.
5. Rosenbaum-Krumme S.J., Freudenberg L.S., Jentzen W., Bockisch A., Nagarajah J. Clin. Nucl. Med. 2012, 37:e47-e52.
6. Sikka A., Kaur M., Agarwal C., Deep G., Agarwal R. Cell Cycle 2012, 11:1374-1382.
7. Zhang X.Y., Wu X.Q., Deng R., Sun T., Feng G.K., Zhu X.F. Cell. Signal. 2013, 25:150-158.
8. Govindarajan R., Ratnasinghe L., Simmons D.L., Siegel E.R., Midathada M.V., Kim L., Kim P.J., Owens R.J., Lang N.P. J. Clin. Oncol. 2007, 25:1476-1481.
9. Koch L. Nat. Rev. Endocrinol. 2010, 6:356.
10. McFarland M.S., Cripps R. Pharmacotherapy 2010, 30:1159-1178.
11. Hannigan G., Troussard A.A., Dedhar S. Nat. Rev. Cancer 2005, 5:51-63.
12. Di-Poi N., Tan N.S., Michalik L., Wahli W., Desvergne B. Mol. Cell 2002, 10:721-733.
13. Younes M.N., Yigitbasi O.G., Yazici Y.D., Jasser S.A., Bucana C.D., El-Naggar A.K., Mills G.B., Myers J.N. Arch. Otolaryngol. Head Neck Surg. 2007, 133:15-23.
14. Eke I., Leonhardt F., Storch K., Hehlgans S., Cordes N. PLoS One 2009, 4:e6434.
15. Wang S., Basson M.D. Cell. Oncol. 2009, 31:273-289.
16. McDonald P.C., Fielding A.B., Dedhar S. J. Cell Sci. 2008, 121:3121-3132.
17. Zheng Y., Ritzenthaler J.D., Sun X., Roman J., Han S. Cancer Res. 2009, 69:896-904.
18. Khyrul W.A., LaLonde D.P., Brown M.C., Levinson H., Turner C.E. J. Biol. Chem. 2004, 279:54131-54139.
19. Williams T., Tjian R. Genes Dev. 1991, 5:670-682.
20. Kambe A., Iguchi G., Moon Y., Kamitani H., Watanabe T., Eling T.E. Biochim. Biophys. Acta 2008, 1783:1211-1219.
21. Desai L.P., Wu Y., Tepper R.S., Gunst S.J. Am. J. Physiol. Lung Cell. Mol. Physiol. 2011, 301:L275-L284.
22. Yamamoto K., Itoh T., Abe D., Shimizu M., Kanda T., Koyama T., Nishikawa M., Tamai T., Ooizumi H., Yamada S. Bioorg. Med. Chem. Lett. 2005, 15:517-522.
23. Marion-Letellier R., Butler M., Dechelotte P., Playford R.J., Ghosh S. Am. J. Clin. Nutr. 2008, 87:939-948.
24. Monaghan-Benson E., Burridge K. J. Biol. Chem. 2009, 284:25602-25611.
25. Reka A.K., Kurapati H., Narala V.R., Bommer G., Chen J., Standiford T.J., Keshamouni V.G. Mol. Cancer Ther. 2010, 9:3221-3232.
26. Morales-Garcia J.A., Luna-Medina R., Alfaro-Cervello C., Cortes-Canteli M., Santos A., Garcia-Verdugo J.M., Perez-Castillo A. Glia 2011, 59:293-307.
27. Ben Sahra I., Le Marchand-Brustel Y., Tanti J.F., Bost F. Mol. Cancer Ther. 2010, 9:1092-1099.
28. Hosono K., Endo H., Takahashi H., Sugiyama M., Uchiyama T., Suzuki K., Nozaki Y., Yoneda K., Fujita K., Yoneda M., Inamori M., Tomatsu A., Chihara T., Shimpo K., Nakagama H., Nakajima A. Mol. Carcinog. 2010, 49:662-671.
29. Brown K.A., Hunger N.I., Docanto M., Simpson E.R. Breast Cancer Res. Treat. 2010, 123:591-596.
30. Cantrell L.A., Zhou C., Mendivil A., Malloy K.M., Gehrig P.A., Bae-Jump V.L. Gynecol. Oncol. 2010, 116:92-98.
31. Wu Y., Zhao X.D., Zhuang Z., Xue Y.J., Cheng H.L., Yin H.X., Shi J.X. Brain Res. 2010, 1322:102-108.
32. Kim H.G., Hien T.T., Han E.H., Hwang Y.P., Choi J.H., Kang K.W., Kwon K.I., Kim B.H., Kim S.K., Song G.Y., Jeong T.C., Jeong H.G. Br. J. Pharmacol. 2011, 162:1096-1108.
33. Fryer L.G., Parbu-Patel A., Carling D. J. Biol. Chem. 2002, 277:25226-25232.
34. Pellikainen J.M., Kosma V.M. Int. J. Cancer 2007, 120:2061-2067.
35. Schwartz B., Melnikova V.O., Tellez C., Mourad-Zeidan A., Blehm K., Zhao Y.J., McCarty M., Adam L., Bar-Eli M. Oncogene 2007, 26:4049-4058.
36. Melnikova V.O., Dobroff A.S., Zigler M., Villares G.J., Braeuer R.R., Wang H., Huang L., Bar-Eli M. PLoS One 2010, 5:e12452.
37. Lu J., Tang Y., Farshidpour M., Cheng Y., Zhang G., Jafarnejad S.M., Yip A., Martinka M., Dong Z., Zhou J., Xu J., Li G. Carcinogenesis 2013, 34:2778-2788.
38. Zhang Y., Li Y., Shibahara S., Takahashi K. Peptides 2008, 29:465-472.
39. Mitchell D.C., Abdelrahim M., Weng J., Stafford L.J., Safe S., Bar-Eli M., Liu M. J. Biol. Chem. 2006, 281:51-58.